EUVIMEDEUVIMED entdecken
FallberichtOpen Access

The Use of Denosumab in a Nonagenarian with Primary Hyperparathyroidism

Tamer Shalaby, Samantha Anandappa, Siva Sivappriyan, Jesse Kumar

European Endocrinology · 2014 · 10 (2) · 151

DOI: 10.17925/ee.2014.10.02.151 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Endocrinology, 2014. Verfasst von Tamer Shalaby und 3 weiteren Autor:innen. Beteiligte Einrichtung: Registrar in Acute Medicine and Endocrinology. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Denosumab is a monoclonal antibody which is currently licensed in the UK drug market for the prevention of skeletal-related events secondary to malignancy (excluding myeloma). This monoclonal antibody is a 6 monthly subcutaneous injection that works by lowering calcium levels. When used in a 90 year old patient with primary hyperparathyroidism it demonstrated a dramatic reduction in the calcium level which had proven difficult to reduce by bisphosphonates and who was not a candidate for surgical intervention.

Schlagwörter

Stichwörter der Autor:innen

Denosumabhypercalcaemiamonoclonal antibodyprimary hyperparathyroidism (pPTH)subcutaneous injection

Autor:innen und Institutionen

  • Registrar in Acute Medicine and Endocrinology.
  • CT1 Endocrinology.
  • Consultant Endocrinologist, Maidstone Hospital, Maidstone, Kent, UK.

Zitieren

APA

Shalaby, T., Anandappa, S., Sivappriyan, S., & Kumar, J. (2014). The Use of Denosumab in a Nonagenarian with Primary Hyperparathyroidism. European Endocrinology, 10(2), 151. https://doi.org/10.17925/ee.2014.10.02.151

Vancouver

Shalaby T, Anandappa S, Sivappriyan S, Kumar J. The Use of Denosumab in a Nonagenarian with Primary Hyperparathyroidism. European Endocrinology. 2014;10(2):151. doi:10.17925/ee.2014.10.02.151

BibTeX
@article{Shalaby2014,
  author = {Shalaby, Tamer and Anandappa, Samantha and Sivappriyan, Siva and Kumar, Jesse},
  title = {The Use of Denosumab in a Nonagenarian with Primary Hyperparathyroidism},
  journal = {European Endocrinology},
  year = {2014},
  volume = {10},
  number = {2},
  pages = {151},
  doi = {10.17925/ee.2014.10.02.151}
}
Kostenlos starten →